Lifetime health consequences and cost-effectiveness of rosiglitazone in combination with metformin for the treatment of type 2 diabetes in Spain

1. Shearer, A.T.
2. Bagust, A.
3. Ampudia-Blasco, F.J.
4. Álvarez, B.M.-L.
5. Escolano, I.P.
6. París, G.